Th-17 cell mediated immune responses to Mycoplasma bovis proteins formulated with Montanide ISA61 VG and curdlan are not sufficient for protection against an experimental challenge with Mycoplasma bovis

Veterinary Immunology and Immunopathology
Tracy PrysliakJose Perez-Casal

Abstract

The current avenues for prevention and/or control of Mycoplasma bovis infection in cattle involve antibiotic treatment of affected animals, herd management practices including separation and or culling infected animals, and the use of commercial vaccines, which offer limited protection. Some bacterin vaccines may cause negative reactions; therefore a different approach is needed, such as the use of recombinant vaccines based on protective antigens formulated with effective adjuvants. The role of Th-17 immune responses in protection against bacterial infections has been investigated for several pathogens. In this study, our goal was to identify M. bovis antigens that may elicit Th-17 protective responses. We tested a vaccine containing M. bovis proteins formulated with Montanide ISA61™ VG and curdlan. After vaccination, the animals were challenged using a BHV-1/M. bovis co-infection model. We detected IL-17 and other cytokines in supernatants of PBMCs incubated with the recall antigens. In addition, we detected antibody and PBMC proliferative responses to the antigens. Despite observing slight decreases in the proportion of the lung lesions and in weight loss in the vaccinated group, we concluded that Th-17 responses to the anti...Continue Reading

References

Oct 6, 2001·American Journal of Respiratory Cell and Molecular Biology·P YeJ K Kolls
Feb 19, 2003·Research in Veterinary Science·R A J Nicholas, R D Ayling
Jul 5, 2003·Veterinary Immunology and Immunopathology·Tony J Vanden Bush, Ricardo F Rosenbusch
Jun 30, 2005·Veterinary Microbiology·Patrizia RobinoSergio Rosati
Jan 24, 2009·Immunological Reviews·Patricia J Dubin, Jay K Kolls
May 12, 2009·Vaccine·Fiona P MaunsellMary B Brown
Dec 17, 2009·Animal Health Research Reviews·John A Ellis
Feb 25, 2010·Allergology International : Official Journal of the Japanese Society of Allergology·Takehiro HigashiSho Matsushita
Jul 14, 2010·The Veterinary Clinics of North America. Food Animal Practice·Jeff L CaswellFernanda Castillo-Alcala
Aug 18, 2010·Infection and Immunity·Jacques van der MerweJose Perez-Casal
Apr 30, 2011·The Veterinary Record·R A J Nicholas
May 10, 2012·Biochemical and Biophysical Research Communications·Hideyuki YoshidaAkihiko Yoshimura
May 15, 2013·Current Opinion in Immunology·Pawan KumarJay K Kolls
Nov 5, 2013·The American Journal of Pathology·Radha GopalShabaana A Khader
Mar 4, 2015·Journal of Comparative Pathology·F RodríguezA Fernández
Mar 25, 2015·Veterinary Immunology and Immunopathology·Satoshi GondairaHajime Nagahata
Jul 28, 2015·Veterinary Microbiology·Christina ZbindenOlga Wellnitz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.